运输署批227条巴士路线调整服务
运输署公布,因应实施多项措施以阻止2019冠状病毒病在社区传播,专营巴士的乘客量受到影响而大幅减少,运输署批准部分巴士路线调整服务,涉及227条路线,有效期7天。
其中九巴调整班次的路线数目为110,新巴为48,城巴为56,九巴/新巴联营为6,九巴/城巴联营为6,新大屿山巴士为1。
获批准调整班次的路线,在晚上10时前(包括繁忙时段及非繁忙时段)的班次最多延长不超过5分钟,而於晚上10时後的班次则最多延长不超过10分钟,惟延长後的班次间距时间不会超过30分钟。另有4条乘客量严重偏低的路线,获准暂停服务或调整服务时间。
运输署已要求巴士公司密切留意相关路线的乘客需求变化,视乎情况在有需要时加强服务,在资源许可下让乘客有较多乘车空间。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.